- Home
- LOOP vs BRNS Comparison
LOOP vs BRNS Comparison
Compare LOOP & BRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LOOP | BRNS |
|---|---|---|
| Founded | 2010 | 2016 |
| Country | Canada | United Kingdom |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 62.8M | 55.9M |
| IPO Year | 2010 | 2021 |
Fundamental Metrics
Financial Performance| Metric | LOOP | BRNS |
|---|---|---|
| Price | $1.30 | $0.56 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $4.00 |
| AVG Volume (30 Days) | 43.8K | ★ 67.7K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 27.27 | 18.85 |
| EPS | ★ N/A | N/A |
| Revenue | $10,889,000.00 | ★ $14,969,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $174.82 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 7016.99 | 1766.46 |
| 52 Week Low | $0.88 | $0.56 |
| 52 Week High | $2.29 | $2.91 |
Technical Indicators
Market Signals| Indicator | LOOP | BRNS |
|---|---|---|
| Relative Strength Index (RSI) | 57.53 | 36.40 |
| Support Level | $1.17 | $0.56 |
| Resistance Level | $1.35 | $0.76 |
| Average True Range (ATR) | 0.06 | 0.07 |
| MACD | -0.01 | -0.00 |
| Stochastic Oscillator | 64.71 | 1.43 |
Price Performance
Historical ComparisonAbout LOOP Loop Industries Inc.
Loop Industries Inc. is a technology and licensing company whose mission is to accelerate the world's shift toward sustainable plastic and away from dependence on fossil fuels. The company owns patented and proprietary technology that depolymerizes no and low value waste PET plastic and polyester fiber, including plastic bottles and packaging, carpet and polyester textile of any color, transparency or condition, and even ocean plastics that have been degraded by the sun and salt, to its base building blocks.
About BRNS Barinthus Biotherapeutics plc
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutics that guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. The company operates as one segment, the research and development of immunotherapies and vaccines.